Like most websites The Medicine Maker uses cookies. In order to deliver a
personalized, responsive service and to improve the site, we remember and store information about how you use
it.
Learn more.
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
Pascal Soriot
The Power List 2016
Pascal Soriot
Executive Director and Chief Executive Officer, AstraZeneca
While at Roche, Soriot was in charge of integrating Genentech, the Californian biotech company, after a $47 billion takeover. He also led AstraZenica in a successful defense against acquisition by Pfizer in 2014 – a feat few envisaged before he took the reins. Soriot worked as a vet before embarking on his career in business.